行情

BTX

BTX

Brooklyn Immunotherapeutics Inc
NASDAQ

实时行情|Nasdaq Last Sale

0.7150
-0.0027
-0.38%
盘后: 0.7300 +0.015 +2.10% 19:17 05/23 EDT
开盘
0.7437
昨收
0.7177
最高
0.7650
最低
0.6901
成交量
23.34万
成交额
0
52周最高
23.34
52周最低
0.6701
市值
4,107.81万
市盈率(TTM)
-0.2610
分时
5日
1月
3月
1年
5年
暂无数据
暂无数据
了解BTX最新的财务预测,通过BTX每股收益,每股净资产,每股现金流等数据分析Brooklyn Immunotherapeutics Inc近期的经营情况,然后做出明智的投资选择。
分析师评级

2位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

0.00%强力推荐
100.00%买入
0.00%中性
0.00%落后大盘
0.00%卖出
目标价格预测
分析师预测BTX价格均价为4.500,最高价位5.00,最低价为4.000。
最高5.00
均价4.500
最低4.000
现价0.7150
EPS
实际EPS
预期EPS
-0.51-0.38-0.26-0.13
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Q1 2022
机构持股
总机构数: 63
机构持股: 1,286.19万
持股比例: 22.39%
总股本: 5,745.19万
类型机构数股数
增持
22
539.77万
建仓
15
234.55万
减持
9
3.89万
平仓
10
25.49万
  • 业绩
  • 资产分布
  • 分红历史
暂无数据
所属板块
生物技术和医学研究
+0.48%
制药与医学研究
+0.70%
高管信息
Non-Executive Chairman/Independent Director
Charles Cherington
President/Chief Executive Officer/Director
Howard Federoff
Chief Administrative Officer
Jay Sial
Chief Scientific Officer
Kevin D' Amour
Vice President - Finance
Sandra Gurrola
Other
Roger Sidhu
Independent Director
Erin Enright
Independent Director
Dennis Langer
Independent Director
Erich Mohr
Independent Director
Heather Redman
暂无数据
暂无数据
BTX 简况
Brooklyn ImmunoTherapeutics, Inc. (Brooklyn), formerly NTN Buzztime, Inc., is a clinical-stage biopharmaceutical company. The Company is focused on cytokine-based therapies in treating patients with cancer, both as a single agent and in combination with other anti-cancer therapies. Brooklyn is engaged in developing IRX-2, a cytokine-based therapy, to treat patients with head and neck cancer. IRX-2 is an allogeneic, reproducible, primary, human cell-derived Interleukin-2 (IL-2) therapeutic with multiple active cytokine components that act on various parts of the immune system, to activate the entire tumor microenvironment. In addition to IL-2, IRX-2 contains multiple human cytokines that promote or enhance an immune response. IRX-2 is administered as an injection around lymph node beds.

微牛提供Brooklyn Immunotherapeutics Inc(NASDAQ-BTX)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的BTX股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易BTX股票基本功能。